Citadel Advisors - KINTARA THERAPEUTICS INC ownership

KINTARA THERAPEUTICS INC's ticker is KTRA and the CUSIP is 49720K101. A total of 25 filers reported holding KINTARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of KINTARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$127,000
+22.1%
248,329
+441.0%
0.00%
Q2 2021$104,000
-22.4%
45,898
-40.3%
0.00%
Q1 2021$134,00076,9050.00%
Other shareholders
KINTARA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
swisspartners Ltd. 275,000$79,0000.08%
Affinity Capital Advisors, LLC 18,590$5,0000.00%
Nantahala Capital Management 116,234$32,0000.00%
Maltin Wealth Management, Inc. 10,000$3,0000.00%
OSAIC HOLDINGS, INC. 48,175$13,0000.00%
WELLS FARGO & COMPANY/MN 390$00.00%
NORTHERN TRUST CORP 44,142$12,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 358,026$99,0000.00%
STATE STREET CORP 116,074$32,0000.00%
View complete list of KINTARA THERAPEUTICS INC shareholders